Hemp bark extract improved memory-test performance in scopolamine-treated mice

Hemp bark extract attenuates scopolamine-induced cognitive dysfunction through multi-target cholinesterase, MAO-B, and antioxidant mechanisms.

Biochemistry and biophysics reports • • Highly Relevant
🤖

AI Summary

The study asked whether hemp extracts could protect against cognitive dysfunction through effects on several biological targets. Researchers compared ethanol extracts from hemp root, stem, bark, leaf, and seed, then tested the bark extract in neuronal cells and in mice given scopolamine, a drug used to induce cognitive deficits. In mice, oral hemp bark extract at 100 and 200 mg/kg improved performance in a passive avoidance test and reduced escape latency in a water maze. These are animal findings, not evidence of benefit in people.

In laboratory tests, the bark extract inhibited acetylcholinesterase, butyrylcholinesterase, and MAO-B, and at 0.2 μg/mL reduced reactive oxygen species and restored superoxide dismutase activity in neuronal cells. Chemical analysis identified CBD, cannabidiolic acid, and cannabichromenic acid; enzyme tests found different cannabinoids active against different targets. The findings suggest multiple possible mechanisms, but this abstract-based summary cannot establish that the extract prevents or treats cognitive decline or Alzheimer’s disease in humans. The abstract does not report the number of animals or study duration.

💡 Key Findings

1
In a scopolamine-induced mouse model, oral hemp bark extract at 100 and 200 mg/kg improved passive avoidance performance and reduced escape latency in a water maze.
Limited
35%
2
Hemp bark extract inhibited acetylcholinesterase, butyrylcholinesterase, and MAO-B in enzyme assays.
Limited
35%
3
In SH-SY5Y neuronal cells, hemp bark extract at 0.2 μg/mL suppressed hydrogen-peroxide-induced reactive oxygen species and recovered superoxide dismutase activity.
Limited
35%
4
CBD, cannabidiolic acid, and cannabichromenic acid were identified in the extract; the abstract reports that cannabichromenic acid inhibited cholinesterases, while CBD and cannabidiolic acid were active against MAO-B.
Limited
35%

📄 Original Abstract

Cognitive decline associated with Alzheimer's disease is driven by several interconnected mechanisms, including impaired cholinergic signaling, MAO-B-linked oxidative stress, and reduced neuronal antioxidant capacity. In this study, ethanol extracts prepared from hemp root, stem, bark, leaf, and seed were compared to identify hemp-derived materials with multi-target neuroprotective potential. Among the tested extracts, hemp bark extract (HBE) showed the most balanced activity profile, inhibiting acetylcholinesterase, butyrylcholinesterase, and MAO-B with IC50 values of 0.56, 0.01, and 0.02 mg/mL, respectively. HBE at 0.2 μg/mL suppressed H2O2-induced intracellular reactive oxygen species formation and recovered superoxide dismutase activity in SH-SY5Y neuronal cells. In a scopolamine-induced mouse model, oral HBE administration at 100 and 200 mg/kg improved performance in the passive avoidance test and reduced escape latency in the water maze test, indicating protection against scopolamine-induced cognitive deficits. Chemical profiling by ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry revealed several cannabinoids in HBE, including cannabidiol, cannabidiolic acid, and cannabichromenic acid. Enzyme assays showed that cannabichromenic acid potently inhibited acetylcholinesterase and butyrylcholinesterase, with IC50 values of 1.3 and 6.6 μM, respectively, whereas cannabidiol and cannabidiolic acid were the most active MAO-B inhibitors, with IC50 values of 2.3 and 5.3 μM. Docking, GNINA rescoring, molecular dynamics simulations, and MM-GBSA/MM-PBSA analyses further supported stable interactions of these cannabinoids with the target enzymes, particularly cannabidiolic acid with acetylcholinesterase and MAO-B. These findings suggest that HBE protects against scopolamine-induced cognitive dysfunction through coordinated cholinesterase inhibition, MAO-B modulation, and antioxidant defense, with cannabidiol, cannabidiolic acid, and cannabichromenic acid acting as key multi-target constituents.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.